Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

DrStockPick.com Watch List!

My Pick for Wednesday November 17, 2009 is:

PWRM, Power3 Medical Products Inc., PWRM.OB

**************************************************************

Many of you have been writing in about PWRM, asking about why we have it featured on our website. One member even asked what makes PWRM so different than the many biomedical companies out there today.

The reason: We feel very stongly about the work PWRM has been doing in the research and development (R&D) of cancer detection.

Over the past few months we’ve been guiding our members to ground breaking PWRM R&D information but eventually it’s up to

...

Nov. 12, 2009 (PR Newswire) — CORALVILLE, Iowa, Nov. 12 /PRNewswire-FirstCall/ — Vivakor, Inc. (OTC Bulletin Board: VIVK) is the keynote presenting company at the founders’ celebration of consumer product specialist, Regeneca International, Inc. (www.regeneca.com). The celebration will be attended by over 200 founders and guests of Regeneca International from across the United States. It will be hosted at the prestigious Balboa Bay Club in Newport Beach, California. Vivakor’s Chairman, Matt Nicosia and CFO, Ed Corrente will both be attending the event.

Event attendee, Dr. Brian Scott , a Regeneca advisory board member and nationally recognized wellness expert, was particularly pleased to learn of Vivakor’s role in the event. “As a healthcare provider and speaker on issues regarding wellness and longevity, it is refreshing to hear the perspective of a company, doing business internationally, which can provide a particular focus on products which extend the length and

...

// < ![CDATA[ yahooBuzzArticleHeadline=ImmunoCellular+Therapeutics+Delivers+on+Key+Milestones+%28OTC%3AIMUC%29; // ]]> ImmunoCellular just announced their lead monoclonal antibody product candidates ICT-109 had positive result in their lead study of detecting cancerous tissues. The results were statically significant suggesting that this antibody can determine if tissues are cancerous or non-cancerous in plasma and serum study sets. These results from the study lead IMUC to believe that this ICT-109 molecule can play an important role in early cancer detection which is absolutely critical in for a most efficient treatment. This will be the second milestone of four that Dr Singh, Ph.D., president and CEO of IMUC, has delivered on time. Singh says IMUC will conduct additional studies testing ICT-109 with other markers to design a robust assay that hopefully will become wildly adopted or the standard in early cancer detection. They will be seeking a partner that specialized in commercial development this type of approach/diagnostic tool. The next milestone that Dr. Singh is scheduled to deliver on is the ...

Micromem Technologies Inc. is a leader in magnetic random access memory (MRAM) technology for use in aerospace/defense, sensors and RFID applications. The company and its wholly-owned subsidiary, Micromem Applied Sensor Technologies Inc. (MAST Inc.), has received an initial purchase order for its sensors from Life Medical Technologies Inc.

Upon completion, the order will total $30 million. Micromem anticipates delivery to begin in 2009 with the bulk expected in 2010, in accordance with fulfilling Life Medical Technologies’ client orders. The initial terms of the purchase order are a request for up to 10 million units and MAST to complete a design, test prototype, and deliver a device approved for commercial use within 30 days.

Micromem’s sensors will be used for Life Medical Technologies’ device developed to enhance breast cancer detection. It is anticipated that the company’s sensors will be included in two components of the device, the wearable portion and the

...

Lifeline Biotechnologies Inc.

(Public, PINK:LLBO)

With the recent gains in Hard to Treat Diseases Inc. (PINK:HTDS) and BioElectronics Corp. (OTC:BIEL), investors were left hungry for more undervalued, high potential biotech companies — Then came LifeLine Biotechnologies Inc (OTC:LLBO). As technology continues to redefine the modern era of medical advancements, certain companies will stand apart from the rest, as is the case with Lifeline Biotechnologies Inc. This company is an innovative medical technology company committed to the improvement of the quality of life through exceptional health care systems, focusing on prevention, early diagnosis, and quick recovery. Recently, the company has made headlines with their innovative Breast Cancer detection system, the First Warning System ™, a dynamic test which collects information over time with an uncanny efficacy. The next several months will prove to be critical for LifeLine Biotechnologies, as they await the FDA’s decision

...

ChromoCure, Inc., a developer and provider of proprietary cancer detection systems, recently announced a co-development agreement with the company’s primary cell preparation and application technology supplier. Under the terms of the agreement, ChromoCure will co-develop a fully integrated chromosomal scanner system for nationwide distribution to pathology and related cancer detection labs.

ChromoCure will collaborate with companies and joint technical research and development efforts to complete a fully automated hybridization system allowing for a complete chromosomal scanning solution. The CS300 system has the ability to perform a full 23-pair chromosomal cross-sectioning for every cell within a sample, while integrating solid tumor incubation equipment for therapeutic and cancer cure protocols testing.

As a leading provider of non-toxic and non-invasive approaches to cancer therapy and cure research, ChromoCure’s systems measure the unique genomic characteristic found in 100 percent of all cancers and never found in normal cells. The company believes its technology is superior and

...

DrStockPick.com Stock Report!

Friday September 4, 2009

**************************************************************

LaSalle International Real Estate Fund, Inc. (NYSE: SLS) today declared a third quarter distribution of $0.063 per share of Common Stock. Dividends on Common Stock will be paid on September 24, 2009 to Common Stockholders of record on September 14, 2009. The ex-dividend date for the Common Stock is September 10, 2009.

ChromoCure, Inc. (PINKSHEETS: KKUR) announced today it executed a Technology Co-Development Agreement with its primary cell preparation and application technology supplier. The co-development agreement calls for the joint-development of a fully integrated chromosomal scanner system for nation-wide distribution to pathology and related

...

Biomoda, Inc.

(Public, OTC:BMOD)

StocksHaven Investments profiles one of the most promising up and coming small cap biotech companies, Biomoda Inc, which has established a medical breakthrough for early lung cancer detection. It is a development-stage company. The Company is an invitro diagnostics company that develops assays, or tests, to detect cancer. These assays are performed in clinical reference laboratories using body-fluid samples. This technology is based on a licensed patent from Los Alamos National Laboratories. The technology is based on a molecule that has an affinity to bind with cancer cells and it fluoresces red under ultra violet light. It is a porphyrin molecule. This technology works with a range of cell types. The Company is in the process of developing a line of assays for a variety of cancers based on adaptations of this technology. Biomoda’s first product

...

Companies featured in this edition of the newsletter: CBAI, ICLK, ITUI, IWEB, MBCI, OMCM, SIHI, SRCO

Markets continued their torrid pace this week on the strength of encouraging reports from two of the most beleaguered economic sectors, which led to gains in all of the major indices following the week’s activities. All told, the Dow ended the week up 2.2%, gaining 198 to close at 9370, bringing its YTD gains to 6.8%. The Nasdaq gained 1.1% on the week, bringing its yearly gains to 26.8% while the S&P 500 and Russell 2000 posted gains of 2.3% and 2.28 % respectively, bringing their yearly gains to 11.9% and 14.6%.

Economic news stole the spotlight this week as earnings season wound down, leaving investors with a more definitive picture of the overall state of recovery than in many weeks prior. The good news started early in the week, as the ISM

...

Recently, Qiagen N.V. (QGEN) announced that it has entered into an agreement to supply molecular screening solutions so that blood donations in Brazil become safer. The agreement covers reagents and instruments for testing samples for HIV and HCV. This is aimed at expanding its presence in Latin America. In general, Qiagen, a research services and diagnostic company, has launched many new products to expand its already rich portfolio of more than 500 products and automated solutions. It is one of the world’s leading providers of technologies and products for the separation, purification and handling of nucleic acids (DNA/RNA). With the objective of further developing its RT-PCR analysis, in May 2009, Qiagen became the first vendor to offer customers fast multiplex real-time RT-PCR Kits. The Rotor-Gene Kit allows the detection of up to four targets per tube and includes optimized protocols for highly precise results on the ...